Russian government tightening domestic pharma patent legislation

The Russian government is considering tightening domestic patent legislation, in a move to respond to numerous calls of global drugmakers, which are unhappy with the level of protection of their original drugs in the local market, reports The Pharma Letter’s local correspondent.

As part of these plans, the government plans to introduce interim measures (including restrictive) during disputes between pharmaceutical companies, that could prevent them from launching of disputed drugs into the market until the end of proceedings.

This has been recently confirmed by the Deputy Head of the Ministry of Industry and Trade, Ekaterina Priezzheva, at the Russian Semashko Pharmaceutical Forum in St Petersburg.